This cohort study compares population-level temporal trends in survival before and after using immune checkpoint inhibitors and antibody-drug conjugates among patients with metastatic urothelial cancer. Click to show full abstract
This cohort study compares population-level temporal trends in survival before and after using immune checkpoint inhibitors and antibody-drug conjugates among patients with metastatic urothelial cancer.
Keywords:
antibody drug;
urothelial cancer;
drug conjugates;
survival trends
Journal Title: JAMA Network Open
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JAMA Network Open
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!